Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension

Published:2020-03-01 Issue:5 Volume:201 Page:575-585
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Hodgson Joshua¹,Swietlik Emilia M.¹²,Salmon Richard M.¹,Hadinnapola Charaka¹,Nikolic Ivana³,Wharton John¹,Guo Jingxu¹,Liley James¹,Haimel Matthias¹⁴⁵,Bleda Marta¹,Southgate Laura⁶⁷,Machado Rajiv D.⁷,Martin Jennifer M.¹⁴⁵,Treacy Carmen M.¹²,Yates Katherine¹⁴⁵,Daugherty Louise C.⁴⁵,Shamardina Olga⁴⁵,Whitehorn Deborah⁴⁵,Holden Simon⁸,Bogaard Harm J.⁹,Church Colin¹⁰,Coghlan Gerry¹¹,Condliffe Robin¹²,Corris Paul A.¹³,Danesino Cesare¹⁴¹⁵,Eyries Mélanie⁹,Gall Henning¹⁶,Ghio Stefano¹⁵,Ghofrani Hossein-Ardeschir¹¹⁶,Gibbs J. Simon R.¹⁷,Girerd Barbara¹⁸¹⁹²⁰,Houweling Arjan C.²¹,Howard Luke¹,Humbert Marc¹⁸¹⁹²⁰,Kiely David G.¹²,Kovacs Gabor²²²³,Lawrie Allan²⁴,MacKenzie Ross Robert V.²⁵,Moledina Shahin²⁶,Montani David¹⁸¹⁹²⁰,Olschewski Andrea²²,Olschewski Horst²²²³,Ouwehand Willem H.⁴⁵,Peacock Andrew J.¹⁰,Pepke-Zaba Joanna²,Prokopenko Inga¹,Rhodes Christopher J.¹,Scelsi Laura¹⁵,Seeger Werner¹⁶,Soubrier Florent⁹,Suntharalingam Jay²⁵,Toshner Mark R.¹²,Trembath Richard C.⁶,Noordegraaf Anton Vonk¹⁹,Wort Stephen J.¹⁷²⁷,Wilkins Martin R.¹,Yu Paul B.³,Li Wei¹,Gräf Stefan¹⁴⁵,Upton Paul D.¹,Morrell Nicholas W.¹⁵

Affiliation:

1. Department of Medicine and

2. Royal Papworth Hospital, Papworth, United Kingdom

3. Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

4. Department of Haematology, University of Cambridge, Cambridge, United Kingdom

5. National Institute for Health Research BioResource–Rare Diseases, Cambridge, United Kingdom

6. Department of Medical and Molecular Genetics, King’s College London, London, United Kingdom

7. Molecular and Clinical Sciences Research Institute, St. George’s University of London, London, United Kingdom

8. Addenbrooke’s Hospital, Cambridge, United Kingdom

9. Département de Génétique, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, and UMR_S 1166-ICAN, INSERM, UPMC Sorbonne Universités, Paris, France

10. Golden Jubilee National Hospital, Glasgow, United Kingdom

11. Royal Free Hospital, London, United Kingdom

12. Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom

13. University of Newcastle, Newcastle, United Kingdom

14. Department of Molecular Medicine, University of Pavia, Pavia, Italy

15. Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

16. University of Giessen and Marburg Lung Center, member of the German Center for Lung Research (DZL) and of the Excellence Cluster Cardio-Pulmonary Institute, Giessen, Germany

17. National Heart and Lung Institute, Imperial College London, London, United Kingdom

18. Faculté de Médecine, Université Paris-Saclay, Université Paris-Sud, Paris, France

19. Service de Pneumologie, Centre de Référence de l’Hypertension Pulmonaire, Assistance Publique–Hôpitaux de Paris, Paris, France

20. Hôpital Bicêtre, Le Kremlin-Bicêtre, INSERM UMR_S 999, Paris, France

21. Department of Clinical Genetics, Amsterdam Universitair Medische Centra, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

22. Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria

23. Medical University of Graz, Graz, Austria

24. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom

25. Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom

26. Great Ormond Street Hospital, London, United Kingdom; and

27. Royal Brompton Hospital, London, United Kingdom

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201906-1141OC

Reference28 articles.

1. Pulmonary Arterial Hypertension

2. Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension

3. Pulmonary arterial hypertension: pathogenesis and clinical management

4. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

5. Genetics and genomics of pulmonary arterial hypertension

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics and precision genomics approaches to pulmonary hypertension;European Respiratory Journal;2024-08-29

2. Pathology and pathobiology of pulmonary hypertension: current insights and future directions;European Respiratory Journal;2024-08-29

3. Mechanisms and treatment of pulmonary arterial hypertension;Nature Reviews Cardiology;2024-08-07

4. Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells;International Journal of Molecular Sciences;2024-07-24

5. Phenotypes in pulmonary hypertension;European Respiratory Journal;2024-07-04